A detailed history of Jefferies Financial Group Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 7,500 shares of LEGN stock, worth $245,999. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,500
Previous 16,500 54.55%
Holding current value
$245,999
Previous $730,000 50.0%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.55 - $59.88 $391,950 - $538,920
-9,000 Reduced 54.55%
7,500 $365,000
Q2 2024

Aug 13, 2024

BUY
$39.5 - $57.22 $651,750 - $944,130
16,500 New
16,500 $730,000
Q4 2023

Feb 13, 2024

BUY
$57.25 - $69.74 $1.1 Million - $1.34 Million
19,250 New
19,250 $1.16 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.49B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.